The invention relates to methods for preparing an olive (Olea europaea subsp. europaea), preferably acebuche (Olea europaea subsp. europaea var. sylvestris) composition, the olive or acebuche composition as prepared, and uses thereof in the prevention or treatment of a bacterial or fungal infection in mammals, preferably infection by antibiotic resistant or multi-resistant bacteria. Other uses relate to functional food additives, in particular an animal feed additive, or to uses in cosmetics.

Described herein are methods for improving or maintaining the barrier integrity of gingival tissue comprising administering an oral care composition comprising a curcurninoid, to the oral cavity of a subject in need thereof.

It relates to a cosmetic composition in the form of a transparent or semi-transparent gel, comprising (a) an oil phase; (b) a surfactant portion comprising a first non-ionic surfactant and a second non-ionic surfactant; (c) an aqueous phase; and (d) at least one C.sub.2-C.sub.6 polyol; wherein the first nonionic surfactant comprises at least one alkyl polyglucoside and the second nonionic surfactant comprises at least one having the following general formula (I) or (II): R(X).sub.nOR′ (I) wherein, R represents a linear or branched C.sub.8-C.sub.30 alkyl group or C.sub.8-C.sub.30 alkenyl group; X represents —OCH.sub.2CH.sub.2— or —OCH.sub.2—CHCH.sub.3—; n represents an integer from 2 to 100; and R′ represents H, or a linear or branched C.sub.8-C.sub.30 alkyl group or C.sub.8-C.sub.30 alkenyl group; (II) wherein, the sum of x+y+z represents an integer from 2 to 100; and R.sub.1, R.sub.2, and R.sub.3, are the same or different and are each independently represents OH, or a linear or branched C.sub.8-C.sub.30 fatty acid ester group, with the proviso that at least one of R.sub.1, R.sub.2 and R.sub.3 is not OH. It also relates to a method for preparing the cosmetic composition and the use thereof. The cosmetic composition has high oil content, superior stability and desirable cleansing efficacy.

##STR00001##

The present invention refers to dermocosmetic formulations for use against skin blemishes, especially melasma. The present invention minimizes or avoids the formation of melasma by acting in several stages of melanogenesis. A preferred embodiment of the invention refers to dermocosmetic formulations that act in several stages of melanogenesis, preferably, in the gene expression of tyrosinase-related proteins (TYRP-1 and TYRP-2) and Endothelin-1 (ET-1). Another embodiment of the invention refers to the cosmetic composition containing a combination of active ingredients that act on the gene expression of tyrosinase-related proteins (TYRP-1 and TYRP-2) and Endothelin-1 (ET-1). In another preferred embodiment of the invention, the use of said cosmetic composition to combat melasma is described.

There is provided a skin-care balm comprising 15% to 45% (w/w) of two or more waxes, wherein a first wax has a melting point of 70° C. to 90° C. and a second wax has a melting point of 30° C. to 60° C., the balm further comprising 45% to 70% (w/w) of an emollient and a skin soothing agent. The skin-care balm can be applied to the skin in the perinasal area. There is also provided a combination product comprising a skin-care balm and a nasal spray product.

The present invention relates to a composition comprising a triglyceride-containing oil, jojoba oil, a free fatty acid or a salt thereof, and squalene. The present invention also relates to the use of such a composition as a skin conditioning agent.

The present disclosure describes a razor cartridge including a housing having a front edge and a rear edge; shaving blades disposed between the front edge and the rear edge; and at least one shaving bar disposed in front of the blade(s) and/or rear of the blade(s) which includes a solid shaving aid composition that includes, relative to the total weight of the solid shaving aid composition: about 15 wt.-% to about 48 wt.-% of a soap base including of one or more fatty acid salts having from about 8 to about 24 carbon atoms and optionally one or more fatty acids having from about 8 to about 24 carbon atoms, at least about 35 wt.-% of one or more polyols including from ˜2 to ˜8 carbon atoms; the polyol selected from a group including glycerol, sorbitol, ethylene glycol, diethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, methylpropane diol glycol.

Composition for topical use including a gelled phase dispersed in a continuous phase, with: the gelled phase including a diol having 3-8 atoms and represented either by formula (Ia): R.sup.a1-C(R.sup.b1)(OH)—C(OH)(R.sup.c1)(R.sup.d1) (Ia), in which each of the Ra1, Rb1, Rc1 and Rd1 radicals represent, independently of one another, a hydrogen atom or saturated aliphatic radical having 1-5 carbon atoms, or by formula (Ib): R.sup.a1-C(R.sup.b1)(OH)—[C(R.sup.e1)(R.sup.f1)]t-C(OH)(R.sup.c1)(R.sup.d1) (Ib), in which t is equal to one, two or three, each of the R.sup.a1, R.sup.b1, R.sup.c1, R.sup.d1, R.sup.e1 and R.sup.f1 radicals represent, independently of one another, a hydrogen atom or saturated aliphatic radical having 1-5 carbon atoms, it being understood that at least one of the Ra1 or Rb1 radicals and/or at least one of the Rc1 or Rd1 radicals do not represent a hydrogen atom, and —a fatty phase including an oil, an emulsifying surfactant system and an emulsifying surfactant.

A process is provided for dyeing keratinous material. The process includes (1) providing an agent (a) that includes (a1) at least one amino-functionalized silicone polymer and (a2) at least one colorant compound. The process further includes (2) providing an agent (b) that includes (b1) water and (b2) at least one fat component. The method includes (3) preparing an application mixture by mixing agents (a) and (b) and (4) applying the application mixture to the keratinous material. Further, the method includes (5) exposing the application mixture to the keratinous material and (6) rinsing the application mixture with water.

A novel cosmetic skin care composition is provided which comprises a solubilized lipophilic peptide, preferably palmitoyl peptide, preferably palmitoyl-GHK-Cu, at a concentration in the range of 0.2-1.1%, the formulation being substantially free of alcohols or preservatives. A method of formulating the composition is also provided to provide a high concentration of the peptide in the final composition.